Live
FierceBiotechParabilis, fresh from inking Regeneron pact, plans IPO to fund tumor drug’s phase 3 pushFierceBiotechPfizer furthers pneumococcal efforts, remains ‘comfortable’ taking on emerging threats: vaccine chiefLabiotechEight Swedish companies spearheading the country’s biotech sceneIlluminaIllumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - TradingViewIlluminaIllumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - PR NewswireEndpoints NewsTrumpRx adds hundreds of generic medicines to siteClinical OMICsSmart Wristband Detects Cardiac Arrest with 92% Sensitivity in Early Clinical StudyEndpoints NewsAnother Paragon offshoot chooses reverse merger, this time for migraine drugs10x Genomics BlogWhy 10x Genomics Stock Is Surging Today - TipRanksClinical OMICsADHD Brain Marker Value in DoubtEndpoints NewsAcceleron leaders and Westlake jumpstart new IPF biotechBio-RadAssessing Bio-Rad Laboratories (BIO) Valuation After Recent Share Price Rebound And ddPCR Growth Prospects - simplywall.st

Archive

Latest Oldest
Total 11564
Page 529 / 643
Query --